Kangmei Pharma | 600518 - Рыночная капитализация





Рыночная капитализация Изменить Дата
Akebia Therapeutics USD 427M 297M 2025-12
Alaunos Therapeutics USD 7M 2M 2026-03
Avita Medical AUD 105.47M 35.32M 2025-12
Dianthus Therapeutics USD 2.71B 1.87B 2026-07
Genomma Lab Internacional MXN 14.52B 505.2M 2026-07
Hypermarcas BRL 13.13B 3.25B 2026-07
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
IQVIA Holdings USD 28.63B 9.76B 2026-03
Jiangsu Hengrui CNY 366.9B 29.67B 2026-03
Kangmei Pharma CNY 24.48B 3.45B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Organon & Co USD 3.47B 1.9B 2026-07
Revvity USD 9.94B 1.03B 2026-03
Tectonic Therapeutic USD 510M 70M 2026-07
Viatris USD 15.73B 1.39B 2026-03
Xeris Pharmaceuticals USD 1.11B 112M 2026-07